Intrastriatal hypoxanthine reduces Na+,K+-ATPase activity and induces oxidative stress in the rats

Metabolic Brain Disease

Volumn 22, Issue 1, 2007, Pages 1-11

  Bavaresco, Caren Serra ^a   Chiarani, Fabria ^a   Wannmacher, Clovis Milton Duval ^a   Netto, Carlos Alexandre ^a   Wyse, Angela Terezinha Souza De ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Hypoxanthine; Intrastriatal injection; Lesch Nyhan; Metabolic disease; Na+,K+ ATPase; Oxidative stress

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); HYPOXANTHINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CHEMOLUMINESCENCE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; HIPPOCAMPUS; LESCH NYHAN SYNDROME; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; ANTIOXIDANTS; CELL MEMBRANE; CEREBRAL CORTEX; CORPUS STRIATUM; HIPPOCAMPUS; HYPOXANTHINE; LESCH-NYHAN SYNDROME; LIPID PEROXIDATION; MICROINJECTIONS; NA(+)-K(+)-EXCHANGING ATPASE; OXIDATIVE STRESS; RATS; RATS, WISTAR;

RATTUS;

EID: 33847687687     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-006-9037-y     Document Type: Article

References (49)

1. Aksenov MY, Markesbery WR (2001) Changes in thiol content and expression of glutathione redox system genes in hippocampus and cerebellum in Alzheimer's disease. Neurosci Lett 302:141-145
2. +-ATPase activity in rat striatum by metabolites accumulated in Lesch Nyhan disease. Int J Devl Neurosci 22:11-17
3. +-ATPase activity and some parameters of oxidative stress in rat striatum. Brain Res 1041:198-204
4. Behl C (2005) Oxidative stress in Alzheimer's disease: Implications for prevention and therapy. Subcell Biochem 38:65-78
5. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein -die binding. Anal Biochem 72:248-254
6. +-ATPase activity. Eur J Neurosci 7:1674-1683
7. +-ATPase: A pathogenetic theory. Med Hypotheses 44:173-178
8. Chan PH, Schmidley JW, Fishman RA, Longar SM (1984) Brain injury, edema and vascular permeability changes induced by oxygen derived free radicals. Neurology 34:315-320
9. + -stimulated ATPase activity. Anal Biochem 157:375-380
10. Dasheiff RM (1980). Benzodiazepinic treatment for Lesch-Nyhan syndrome? Dev Med Child Neurol 22:101-102
11. Erecinska M, Silver IA (1994). Ions and energy in mammalian brain. Prog Neurobiol 7:21-29
12. Floyd RA (1999) Antioxidants, oxidative stress and degenerative neurological disorders. Proc Soc Exp Biol Med 222:236-245
13. +-ATPase function is a possible mechanism for striatal neurodegeneration in hypoxic-ischemic newborn piglets. Brain Res Mol Brain Res 81:94-102
14. Gonzalez Flecha B, Llesuy S, Boveris A (1991) Hydroperoxide-initiated chemiluminescence: An assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic Biol Med 10:93-100
15. +-pump in epilepsy. Ann Neurol 16 (Suppl.):128-134
16. Hagberg H, Andersson P, Lacarewicz J, Jacobson I, Butcher S, Sandberg M (1987) Extracellular adenosine, inosine, hypoxanthine and xanthine to tissue nucleotides and purines in rat striatum during transient ischemia. J Neurochem 49:227-231
17. Halliwell B (1996) Free radicals, proteins and DNA: Oxidative damage versus redox regulation. Biochem Soc Trans 24:1023-1027
18. Halliwell B (2002) Hypothesis: Proteasomal dysfunction: A primary event in neurogeneration that leads to nitrative and oxidative stress and subsequent cell death. Ann NY Acad Sci 962:182-94
19. Harkness RA, McCreanor GM, Watts RW (1988) Lesch-Nyhan syndrome and its pathogenesis: Purine concentrations in plasma and in urine with metabolite profiles in CSF. J Inher Metab Dis 11:239-252
20. +- ATPase activities in Alzheimer's disease brains. Neurosci Lett 254:141-144
21. +-ATPase activity by oxygen free radicals. Neuroreport 7:333-337
22. Jinnah HA, Friedmann T (2001) Lesch Nyhan disease and it variants. In: Scriver, CR, Beaudet AL, Sly WS, Valle D (eds.) The Metabolic and Molecular Bases of Inherited Disease, eighth ed, McGraw-Hill, New York, pp. 2537-2569
23. Jinnah HA, Gage FH, Friedmann T (1990) Animal models of Lesch-Nyhan syndrome. Brain Res Bull 25:467-475
24. Jones DH, Matus AI (1974) Isolation of synaptic plasma membrane from brain by combined flotationsedimentation density gradient centrifugation. Biochim Biophys Acta 356:276-287
25. Kisch SJ, Fox IH, Kapur BM, Lloyd KG, Hornykiewicz O (1985) Brain benzodiazepine receptor binding and purine concentration in Lesch-Nyhan. Brain Res 336:117-123
26. Lees GJ (1993) Contributory mechanism in the causation of neurodegenerative disorders. Neurosci 54:287-322
27. Lissi E, Pascual C, Del Castillo MD (1992) Luminol luminescence induced by 2,2′-azo-bis (2-amidinopropane) thermolysis. Free Rad Res Comm 17:299-311
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-267
29. Ma MHY, Stacey NC, Connolly GP (2001) Hypoxanthine impairs morphogenesis and enhances proliferation of a neuroblastoma model of Lesch Nyhan syndrome. J Neurosci Res 63:500-508
30. Mahon S, Deniau JM, Charpier S (2004) Corticostriatal plasticity: Life after the depression. Trends Neurosci 27:460-467
31. Morel P, Faucommeau B, Page G (1998). Inhibitory effect of ascorbic acid on dopamine uptake by rat striatal synaptosomes: Relationship to lipid peroxidation and oxidation of protein sulfhydryl groups. Neurosci Res 32:171-179
32. Nyhan WL, Oliver WJ, Lesch M (1965) A familial disorder or uric acid metabolism and central nervous system function II. J Pediatr 67:439-444
33. Palmer GC (1987) Free radicals generated by xanthine oxidase - hypoxanthine damage adenylate cyclase and ATPase in gerbil cerebral cortex. Metab Brain Dis 2:243-257
34. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, second ed. Academic Press, London
35. Puig JG, Jimenez ML, Mateos FA, Fox IH (1989) Adenine nucleotide turnover in hypoxanthine-guanine phosphoribosyl-transferase: Evidence for an increased contribution of purine biosyntheses de novo. Metabolism 38: 410-418
36. +-ATPase in the brain. Epilepsia 33:58-64
37. Rijksen G, Staal GEJ, Van Der Vlist MJM, Beerner FA, Troost J, Gutensohn W, Van Laarhoven JPRM, De Bruyn CHMM (1981) Partial hypoxanthine-guanine phosphoribosyl transferase deficiency with full expression of the Lesch - Nyhan syndrome. Hum Gen 57:39-47
38. Schmidt H, Siems WG, Grune T, Grauel EL (1995) Concentration of purine compounds in the cerebrospinal fluid of infants suffering from sepsis, convulsions and hydrocephalus. J Perinat Med 23:167-174
39. Visser JE, Bär PR, Jinnah HA (2000) Lesch-Nyhan disease and the basal ganglia. Brain Res Bull 32:449-475
40. Visser JE, Smith DW, Moy SS, Breese GR, Friedmann T, Rothstein JD, Jinnah HA (2002) Oxidative stress and dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. Brain Res Dev Brain Res 133:127-139
41. Wooten GF, Collins RC (1980) Regional glicose utilization following intrastriatal injection of kainic acid. Brain Res. 201:173-184
42. +-ATPase activity in experimental phenylketonuria. Metab Brain Dis 14:95-101
43. +-ATPase activity after brain ischemia. Neurochem Res 25:969-973
44. +-ATPase to hypertrophy and its marker genes in cardiac myocytes. J Biol Chem 274:19323-19328
45. +-ATPase - mediated signal transduction: From protein interaction to cellular function. Molecular Interventions 3:157-168
46. Xiao AY, Wei L, Xia S, Rothman S, Yu SP (2002) Ionic mechanism of ouabain-induced concurrent apoptosis and necrosis in individual cultured cortical neurons. J Neurosci 22:1350-1362
47. Yang GY, Chen SF, Kinouchi H, Chan PH, Weinstein PR (1992) Edema, cation content, and ATPase activity after middle cerebral artery occlusion in rats. Stroke 23:1331-1336
48. Zaczek R, Simonton S, Coyle JT (1980) Local and distant neuronal degeneration following intrastriatal injection of kainic acid. J Neuropathol Exp Neurol 39:245-264
49. Zarkovic K (2003) 4-hydroxynonenal and neurodegenerative diseases. Mol Aspects Med 24:293-303